The upregulation of interferon-related genes (Stat1, Irf1) suggests activation of antitumor immune responses (Ling et al., 2023), while downregulation of metabolic enzymes like Enox1 may indicate metabolic reprogramming of cancer cells (Linchong et al., 2021). This evidence concerns the gene IRF1 and cancer.